These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 12495659)
1. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line. Avery ML; Meek CE; Audus KL Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659 [TBL] [Abstract][Full Text] [Related]
2. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157 [TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Chun YJ; Kim MY; Guengerich FP Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061 [TBL] [Abstract][Full Text] [Related]
5. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats. Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789 [TBL] [Abstract][Full Text] [Related]
6. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2. Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes. Dhawan A; Parmar D; Dayal M; Seth PK Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197 [TBL] [Abstract][Full Text] [Related]
8. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats. Spatzenegger M; Horsmans Y; Verbeeck RK Pharmacol Toxicol; 2000 Feb; 86(2):71-7. PubMed ID: 10728918 [TBL] [Abstract][Full Text] [Related]
9. EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male Pigs. Zamaratskaia G; Zlabek V Sensors (Basel); 2009; 9(3):2134-47. PubMed ID: 22574004 [TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes evidence for catalytic activity and mRNA expression. Dey A; Parmar D; Dayal M; Dhawan A; Seth PK Life Sci; 2001 Jun; 69(4):383-93. PubMed ID: 11459429 [TBL] [Abstract][Full Text] [Related]
11. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2. Ueng YF; Kuo YH; Peng HC; Chen TL; Jan WC; Peter Guengerich F; Lin YL Xenobiotica; 2003 Jun; 33(6):603-13. PubMed ID: 12851037 [TBL] [Abstract][Full Text] [Related]
12. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta. Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Weaver RJ; Thompson S; Smith G; Dickins M; Elcombe CR; Mayer RT; Burke MD Biochem Pharmacol; 1994 Mar; 47(5):763-73. PubMed ID: 8135852 [TBL] [Abstract][Full Text] [Related]
14. Inducibility of enzyme activities associated with the cytochrome P-450 1A family, ethoxyresorufin O-deethylase, and methoxyresorufin O-demethylase in human hepatocyte lines derived from normal liver tissue. Roberts EA; Xie ZW; Yang S; Lipa J Drug Metab Dispos; 1993; 21(1):56-61. PubMed ID: 8095227 [TBL] [Abstract][Full Text] [Related]
15. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2. Tsyrlov IB; Goldfarb IS; Gelboin HV Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012 [TBL] [Abstract][Full Text] [Related]
16. Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Morse DC; Stein AP; Thomas PE; Lowndes HE Toxicol Appl Pharmacol; 1998 Sep; 152(1):232-9. PubMed ID: 9772218 [TBL] [Abstract][Full Text] [Related]
17. Further immunochemical and biocatalytic characterization of CYP1A1 from feral leaping mullet liver (Liza saliens) microsomes. Sen A; Arinç E Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):235-44. PubMed ID: 11048673 [TBL] [Abstract][Full Text] [Related]
18. A high-throughput cell-based reporter gene system for measurement of CYP1A1 induction. Cui X; Palamanda J; Norton L; Thomas A; Lau YY; White RE; Cheng KC J Pharmacol Toxicol Methods; 2002; 47(3):143-51. PubMed ID: 12628305 [TBL] [Abstract][Full Text] [Related]
19. Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum. Iba MM; Storch A; Ghosal A; Bennett S; Reuhl KR; Lowndes HE Arch Toxicol; 2003 Oct; 77(10):547-54. PubMed ID: 14574441 [TBL] [Abstract][Full Text] [Related]
20. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals. Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]